SBE's 3rd International Conference on Accelerating Biopharmaceutical Development

Including Quality by Design in Biologics (QbD)
February 24-27, 2013

The theme of the AccBio/QbD 2013 is "Meeting Current Challenges in Therapeutic Protein Technical Development." The conference, co-chaired by Jim Thomas (Amgen) and Reed Harris (Genentech) will include a special 1 ½ day portion focused on application of Quality by Design in Biologics and will be chaired by Beth Junker (Merck).

This 4-day conference (February 24-27) is unique in that it provides attendees with a multidisciplinary approach. High level talks by well known speakers will help to provide insight into accelerating biopharmaceutical development through different functional units such as process development and manufacturing. The conference will also have sessions featuring the application of Quality by Design in biologics, focusing on how product attributes and processes relate to performance and innovations in biopharmaceutical processing. 

Session Descriptions and Confirmed Speakers


Keynote Presentation: Kevin Bailey

Optimizing the Speed and Throughput of Therapeutic Antibody Development Advances in target discovery and validation coupled with the ability to generate fully human antibodies against these targets is increasing the rate with which biotechnology companies can move promising new therapeutics into...

Keynote Presentation: Ganesh Kaundinya

Complexity in biological products – Applications to QbD Most biological products, whether derived from natural sources or recombinantly expressed, are heterogeneous mixtures of distinct molecular entities and hence, complex. The heterogeneity is a result of dynamic and subtle variations in the...


Proceedings of the 3rd AccBio / QbD Proceedings are now available: